What is the role of inhaled antibiotic therapy for nosocomial pneumonia?

Updated: Jul 30, 2018
  • Author: Burke A Cunha, MD; Chief Editor: John L Brusch, MD, FACP  more...
  • Print


The use of inhaled antibiotic therapy should be generally limited to cases of VAP produced by gram-negative bacilli that are sensitive only to aminoglycosides, colistin, or polymyxin B. These antibiotics should also be administered systemically. [24]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!